TWD 6.1
(0.16%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 1.6 Million TWD | -59.52% |
2022 | 3.96 Million TWD | 427.53% |
2021 | 752 Thousand TWD | -80.54% |
2020 | 3.86 Million TWD | -49.7% |
2019 | 7.68 Million TWD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q2 | 402 Thousand TWD | 0.0% |
2024 Q1 | 402 Thousand TWD | 0.0% |
2023 Q4 | 1.6 Million TWD | 0.0% |
2023 FY | 1.6 Million TWD | -59.52% |
2023 Q3 | 1.6 Million TWD | -42.52% |
2023 Q2 | 2.79 Million TWD | 0.0% |
2023 Q1 | 2.79 Million TWD | -29.57% |
2022 Q4 | 3.96 Million TWD | 0.0% |
2022 FY | 3.96 Million TWD | 427.53% |
2022 Q3 | 3.96 Million TWD | 0.0% |
2021 FY | 752 Thousand TWD | -80.54% |
2020 FY | 3.86 Million TWD | -49.7% |
2019 FY | - TWD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
SYN-TECH Chem. & Pharm. Co., Ltd. | 60.65 Million TWD | 97.352% |
Level Biotechnology Inc. | 9.88 Million TWD | 83.753% |
TaiMed Biologics Inc. | 521.7 Million TWD | 99.692% |
GlycoNex Incorporation | - TWD | -Infinity% |
GeneReach Biotechnology Corp. | 97.74 Million TWD | 98.357% |
OBI Pharma, Inc. | 439.88 Million TWD | 99.635% |
Taiwan Advance Bio-Pharmaceutical Inc. | 86.89 Million TWD | 98.152% |
Genomics BioSci & Tech. Co.,Ltd. | 222.24 Million TWD | 99.277% |
Visgeneer Inc. | 114.17 Million TWD | 98.593% |
Neith Corporation | 714 Thousand TWD | -124.93% |
Lumosa Therapeutics Co., Ltd. | 8.11 Million TWD | 80.214% |
Medigen Vaccine Biologics Corporation | 254.35 Million TWD | 99.369% |
TaiwanJ Pharmaceuticals Co., Ltd. | 472 Thousand TWD | -240.254% |
Enimmune corporation | 1.75 Million TWD | 8.698% |
TaiRx, Inc. | 8.96 Million TWD | 82.094% |
CHO Pharma, Inc. | - TWD | -Infinity% |
BioLASCO Taiwan Co., Ltd. | 51.43 Million TWD | 96.877% |
Sunny Pharmtech Inc. | 376.29 Million TWD | 99.573% |
Ever Supreme Bio Technology Co., Ltd | 503 Thousand TWD | -219.284% |
Feng Chi Biotech Corp. | 8.14 Million TWD | 80.292% |
Lukas Biomedical Inc. | 69.9 Million TWD | 97.703% |
RBC Bioscience Corporation | 412.59 Million TWD | 99.611% |
NaviFUS Corp. | 25.83 Million TWD | 93.784% |
BRIM Biotechnology, Inc. | 108 Thousand TWD | -1387.037% |
Shine-On BioMedical Co.,Ltd. | - TWD | -Infinity% |
Great Novel Therapeutics Biotech & Medicals | 10.88 Million TWD | 85.24% |
Sagittarius Life Science Corp | 6.25 Million TWD | 74.32% |
Bio Preventive Medicine Corp. | 106.2 Million TWD | 98.488% |
Advagene Biopharma Co., Ltd. | - TWD | -Infinity% |
BioGend Therapeutics Co., Ltd. | 9.44 Million TWD | 82.989% |
G&E Herbal Biotechnology Co., Ltd. | 1.29 Million TWD | -24.111% |
Andros Pharmaceuticals Co.,Ltd | 22.02 Million TWD | 92.708% |
Lin BioScience, Inc. | 29.02 Million TWD | 94.467% |
Anti-Microbial Savior BioteQ Co., Ltd | - TWD | -Infinity% |
AP Biosciences Inc | 70.42 Million TWD | 97.72% |
Sunmax Biotechnology Co., Ltd. | 144.77 Million TWD | 98.891% |
Syngen Biotech Co.,Ltd. | 386.07 Million TWD | 99.584% |
EirGenix Inc. | 436.54 Million TWD | 99.632% |
Pharmosa Biopharm Inc. | 118.41 Million TWD | 98.644% |
Mycenax Biotech Inc. | 569.78 Million TWD | 99.718% |
SynCore Biotechnology Co.,Ltd | - TWD | -Infinity% |
NeoCore Technology Co., Ltd. | 33.65 Million TWD | 95.228% |
VBI | - TWD | -Infinity% |
BiOptic Inc. | 85.79 Million TWD | 98.128% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | 366 Million TWD | 99.561% |
Sinew Pharma Inc. | - TWD | -Infinity% |
Greenyn Biotechnology Co., Ltd | 55.91 Million TWD | 97.128% |
Medigen Biotechnology Corp. | 449.09 Million TWD | 99.642% |
3D Global Biotech Inc. | 4.08 Million TWD | 60.657% |
Intech Biopharm Corporation | 970.4 Million TWD | 99.835% |
Oneness Biotech Co., Ltd. | 397.95 Million TWD | 99.596% |
TWi Biotechnology, Inc. | 5.6 Million TWD | 71.337% |
TCI GENE Inc. | - TWD | -Infinity% |
MegaPro Biomedical Co., Ltd | 5.62 Million TWD | 71.464% |
Senhwa Biosciences, Inc. | 3.28 Million TWD | 51.141% |
Taiwan Bio Therapeutics Co., Ltd | 250.51 Million TWD | 99.359% |
NatureWise Biotech & Medicals Corporation | 3.26 Million TWD | 50.812% |
PharmaEngine, Inc. | 7.14 Million TWD | 77.516% |
Savior Lifetec Corporation | 257.03 Million TWD | 99.375% |
TaiGen Biopharmaceuticals Holdings Limited | 58.71 Million TWD | 97.265% |
Meribank Biotech Co., Ltd | 14.81 Million TWD | 89.157% |
Acepodia, Inc. | 233.45 Million TWD | 99.312% |
Caliway Biopharmaceuticals Co., Ltd. | 11.87 Million TWD | 86.475% |